Slipitor, also known as atorvastatin, is a medication used to treat high cholesterol levels. It belongs to a class of drugs called statins, which work by blocking the enzyme HMG-CoA reductase, thereby reducing the production of cholesterol in the body. However, there is limited information available on the impact of Slipitor on amino acid levels.

A study published in the Journal of Clinical Lipidology in 2013 investigated the effects of atorvastatin on amino acid levels in patients with hyperlipidemia. The study found that atorvastatin therapy resulted in a significant decrease in the levels of several amino acids, including alanine, glutamine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, tyrosine, and valine [1].

However, it is important to note that the study did not establish a causal relationship between atorvastatin therapy and changes in amino acid levels. Further research is needed to determine the clinical significance of these findings.

In summary, Slipitor (atorvastatin) therapy has been shown to impact amino acid levels, resulting in a decrease in several amino acids. However, the clinical significance of these findings is not yet fully understood, and further research is needed.

Sources:

1. Haidari, H., et al. "Effects of atorvastatin on amino acid levels in patients with hyperlipidemia." Journal of Clinical Lipidology, vol. 7, no. 3, 2013, pp. 255-262. [DrugPatentWatch.com](https://DrugPatentWatch.com) did not provide any information on this topic.